NDC Package 0143-9182-01 Methylprednisolone Sodium Succinate

Injection, Powder, For Solution Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0143-9182-01
Package Description:
1 VIAL, MULTI-DOSE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, MULTI-DOSE
Product Code:
Proprietary Name:
Methylprednisolone Sodium Succinate
Non-Proprietary Name:
Methylprednisolone Sodium Succinate
Substance Name:
Methylprednisolone Sodium Succinate
Usage Information:
When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of Methylprednisolone Sodium Succinate for Injection, USP, is indicated as follows:
11-Digit NDC Billing Format:
00143918201
NDC to RxNorm Crosswalk:
  • RxCUI: 314099 - methylPREDNISolone 62.5 MG/ML Injectable Solution
  • RxCUI: 314099 - methylprednisolone 62.5 MG/ML Injectable Solution
  • RxCUI: 314099 - methylprednisolone (as methylprednisolone sodium succinate) 62.5 MG/ML Injectable Solution
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hikma Pharmaceuticals Usa Inc.
    Dosage Form:
    Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Sample Package:
    No
    FDA Application Number:
    ANDA202691
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    01-15-2024
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0143-9182-01?

    The NDC Packaged Code 0143-9182-01 is assigned to a package of 1 vial, multi-dose in 1 carton / 1 injection, powder, for solution in 1 vial, multi-dose of Methylprednisolone Sodium Succinate, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. The product's dosage form is injection, powder, for solution and is administered via intramuscular; intravenous form.

    Is NDC 0143-9182 included in the NDC Directory?

    Yes, Methylprednisolone Sodium Succinate with product code 0143-9182 is active and included in the NDC Directory. The product was first marketed by Hikma Pharmaceuticals Usa Inc. on January 15, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0143-9182-01?

    The 11-digit format is 00143918201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20143-9182-015-4-200143-9182-01